M.D. Recent clinical trials have definitely shown that reducing cholesterol levels prevents cardiovascular disease and lowers total mortality. Other studies, conducted over several decades, using multiple research methods confirm the evidence linking risk factors and cardiovascular disease. Angiographic and functional studies in atherosclerosis confirm that aggressive risk factor modification retards the progression of vascular disease and stabilizes vulnerable plaque. Comprehensive risk assessment and therapy is now recognized as an integral part of the care for patients with cardiovascular disease and those at high risk. Multiple treatment modalities are explored for every patient to determine the optimum approach.
Patients also have access to research protocols and clinical trials.
The program is designed for people who have a history of heart disease, are at risk for heart disease or simply want to know their risk for future cardiovascular events. The Annual PACT Symposiums at the Fairchild Auditorium are always well attended Faculty and Staff Stanley G. Rockson, M.D .